- Home
- INTG vs LPCN Comparison
INTG vs LPCN Comparison
Compare INTG & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTG
- LPCN
- Stock Information
- Founded
- INTG 1965
- LPCN 1997
- Country
- INTG United States
- LPCN United States
- Employees
- INTG N/A
- LPCN N/A
- Industry
- INTG Building operators
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- INTG Real Estate
- LPCN Health Care
- Exchange
- INTG Nasdaq
- LPCN Nasdaq
- Market Cap
- INTG 30.8M
- LPCN 36.8M
- IPO Year
- INTG N/A
- LPCN N/A
- Fundamental
- Price
- INTG $14.05
- LPCN $4.87
- Analyst Decision
- INTG
- LPCN Strong Buy
- Analyst Count
- INTG 0
- LPCN 1
- Target Price
- INTG N/A
- LPCN $10.00
- AVG Volume (30 Days)
- INTG 3.3K
- LPCN 33.5K
- Earning Date
- INTG 02-18-2025
- LPCN 11-07-2024
- Dividend Yield
- INTG N/A
- LPCN N/A
- EPS Growth
- INTG N/A
- LPCN N/A
- EPS
- INTG N/A
- LPCN N/A
- Revenue
- INTG $59,536,000.00
- LPCN $7,922,926.00
- Revenue This Year
- INTG N/A
- LPCN N/A
- Revenue Next Year
- INTG N/A
- LPCN N/A
- P/E Ratio
- INTG N/A
- LPCN N/A
- Revenue Growth
- INTG 4.95
- LPCN N/A
- 52 Week Low
- INTG $13.10
- LPCN $2.44
- 52 Week High
- INTG $26.68
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- INTG 45.46
- LPCN 47.54
- Support Level
- INTG $13.70
- LPCN $4.68
- Resistance Level
- INTG $14.30
- LPCN $5.28
- Average True Range (ATR)
- INTG 0.35
- LPCN 0.36
- MACD
- INTG 0.02
- LPCN -0.01
- Stochastic Oscillator
- INTG 28.23
- LPCN 44.44
About INTG Intergroup Corporation (The)
The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.